How can I (or my colleague) apply?
Please contact the chairs of CVCT
-
Pr Faiez Zannad
-
Dr Bertram Pitt
What Can the Fellowship Offer?
-
Work with Executive/Steering Committees and clinician scientists in Boehringer Ingelheim on CV outcome trial(s).
-
Undertake analyses of datasets that complements the fellow’s interest.
APPLICATION DEADLINE: January 31, 2021
ADVANCED FELLOWSHIP IN CV TRIALS
What problem are we trying to solve?
-
Without a steady supply of talent, innovation in outcome-based cardiovascular drug/device development is at risk.
-
Currently, there are only limited opportunities, if any, for clinical academics to gain expertise in the conduct of these global trials.
Why Boehringer Ingelheim?
-
Boehringer Ingelheim has a strong legacy of cardiovascular outcome trials, including EMPA-REG OUTCOME and Emperor-Reduced trials.
-
As a family-owned company, Boehringer Ingelheim plans in generations.
-
This partnership with CVCT is a unique opportunity to nurture future leaders in cardiovascular medicine.